These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 2715006)
21. Anti-TAG-72 antibody B72.3--immunological and clinical effects in ovarian carcinoma. Schmolling J; Reinsberg J; Wagner U; Krebs D Hybridoma; 1997 Feb; 16(1):53-8. PubMed ID: 9085129 [TBL] [Abstract][Full Text] [Related]
22. Clinical comparison of radiolocalization of two monoclonal antibodies (mAbs) against the TAG-72 antigen. Divgi CR; Scott AM; McDermott K; Fallone PS; Hilton S; Siler K; Carmichael N; Daghighian F; Finn RD; Cohen AM Nucl Med Biol; 1994 Jan; 21(1):9-15. PubMed ID: 9234259 [TBL] [Abstract][Full Text] [Related]
23. Comparative study of RIS with the 131I-OC 125 F(ab')2 Mab and CT scan prior to second look operation for ovarian cancer. Papazefkos V; Michalas S; Papantoniou V; Datseris J; Athanasiadis P; Akrivos T; Leonti A; Xygakis A; Aravantinos D Eur J Obstet Gynecol Reprod Biol; 1990 Dec; 37(3):271-7. PubMed ID: 2227070 [TBL] [Abstract][Full Text] [Related]
24. In vivo antitumor activity of a monoclonal antibody-Vinca alkaloid immunoconjugate directed against a solid tumor membrane antigen characterized by heterogeneous expression and noninternalization of antibody-antigen complexes. Starling JJ; Maciak RS; Law KL; Hinson NA; Briggs SL; Laguzza BC; Johnson DA Cancer Res; 1991 Jun; 51(11):2965-72. PubMed ID: 2032233 [TBL] [Abstract][Full Text] [Related]
25. Antibody-guided radiolocalisation of tumours in patients with testicular or ovarian cancer using two radioiodinated monoclonal antibodies to placental alkaline phosphatase. Epenetos AA; Carr D; Johnson PM; Bodmer WF; Lavender JP Br J Radiol; 1986 Feb; 59(698):117-25. PubMed ID: 3947819 [TBL] [Abstract][Full Text] [Related]
26. Quantitative and qualitative aspects of radiolocalization in colon cancer patients of intravenously administered MAb B72.3. Esteban JM; Colcher D; Sugarbaker P; Carrasquillo JA; Bryant G; Thor A; Reynolds JC; Larson SM; Schlom J Int J Cancer; 1987 Jan; 39(1):50-9. PubMed ID: 3793270 [TBL] [Abstract][Full Text] [Related]
27. Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue. Molinolo A; Simpson JF; Thor A; Schlom J Cancer Res; 1990 Feb; 50(4):1291-8. PubMed ID: 2297774 [TBL] [Abstract][Full Text] [Related]
28. [Visualization of malignant tumors in the abdomen using radiolabelled monoclonal antibodies]. Pateisky N; Philipp K; Burchell J; Skodler W Geburtshilfe Frauenheilkd; 1984 Oct; 44(10):623-6. PubMed ID: 6097499 [TBL] [Abstract][Full Text] [Related]
30. Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen. Muraro R; Kuroki M; Wunderlich D; Poole DJ; Colcher D; Thor A; Greiner JW; Simpson JF; Molinolo A; Noguchi P Cancer Res; 1988 Aug; 48(16):4588-96. PubMed ID: 3396010 [TBL] [Abstract][Full Text] [Related]
31. Radioimmunoscintigraphy in patients with ovarian cancer. Kalofonos HP; Karamouzis MV; Epenetos AA Acta Oncol; 2001; 40(5):549-57. PubMed ID: 11669325 [TBL] [Abstract][Full Text] [Related]
32. Characterization and biodistribution of recombinant and recombinant/chimeric constructs of monoclonal antibody B72.3. Colcher D; Milenic D; Roselli M; Raubitschek A; Yarranton G; King D; Adair J; Whittle N; Bodmer M; Schlom J Cancer Res; 1989 Apr; 49(7):1738-45. PubMed ID: 2924317 [TBL] [Abstract][Full Text] [Related]
33. In vivo and in vitro clinical applications of monoclonal antibodies against TAG-72. Colcher D; Milenic DE; Ferroni P; Roselli M; Schlom J Int J Rad Appl Instrum B; 1991; 18(4):395-401. PubMed ID: 1864728 [TBL] [Abstract][Full Text] [Related]
35. The role of radioimmunoscintigraphy and computed tomography scan prior to reassessment laparotomy of patients with ovarian carcinoma. A preliminary report. Method MW; Serafini AN; Averette HE; Rodriguez M; Penalver MA; Sevin BU Cancer; 1996 Jun; 77(11):2286-93. PubMed ID: 8635097 [TBL] [Abstract][Full Text] [Related]
36. Specific interference with the determination of the tumour-associated glycoprotein 72 by human anti-idiotypic antibodies formed after treatment with the anti-tumour-associated glycoprotein 72 antibody B72.3. Reinsberg J; Gast B; Schmolling J; Wagner U; Krebs D Eur J Clin Chem Clin Biochem; 1994 Sep; 32(9):691-6. PubMed ID: 7865625 [TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibodies recognizing tumor-associated antigen of human ovarian mucinous cystadenocarcinomas. Bhattacharya M; Chatterjee SK; Barlow JJ; Fuji H Cancer Res; 1982 May; 42(5):1650-4. PubMed ID: 6175395 [TBL] [Abstract][Full Text] [Related]
38. Tumor targeting with monoclonal antibody B72.3. Schlom J; Colcher D; Roselli M; Carrasquillo JA; Reynolds JC; Larson SM; Sugarbaker P; Tuttle SE; Martin EW Int J Rad Appl Instrum B; 1989; 16(2):137-42. PubMed ID: 2654088 [No Abstract] [Full Text] [Related]
39. Monoclonal antibody against human ovarian tumor-associated antigens. Poels LG; Peters D; van Megen Y; Vooijs GP; Verheyen RN; Willemen A; van Niekerk CC; Jap PH; Mungyer G; Kenemans P J Natl Cancer Inst; 1986 May; 76(5):781-91. PubMed ID: 3517452 [TBL] [Abstract][Full Text] [Related]
40. Radioimmunoscintigraphy of ovarian cancer with 131-iodine labeled OC-125 antibody fragments. Barzen G; Mayr AC; Langer M; Becker R; Cordes M; Zwicker C; Koppenhagen K; Felix R Eur J Nucl Med; 1989; 15(1):42-8. PubMed ID: 2917583 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]